Stocktoria

Turn Therapeutics Inc. TTRX

Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2025-10-08

Turn Therapeutics Inc. statistics & valuation

Market cap$206.4M
P / B44.0×
Return on equity-68.2%
Return on capital-95.1%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Gross margin (%)
20242025
Operating margin (%)
20242025
Return on equity (%)
-68.20% 20242025
Shares outstanding
26.8M 29.4M 20242025
Net debt ($)
20242025
Share buybacks ($)
20242025
Return on assets (%)
-86.30% -26.30% 20242025
Free cash flow margin (%)
20242025
Debt / equity (×)
20242025
EPS ($)
-$0.07 -$0.12 20242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024
Return on assets-26.3%-86.3%
Return on equity-68.2%996.7%
Current ratio0.871.55

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.